458 related articles for article (PubMed ID: 34445670)
1. Adaptive Immunity and the Risk of Autoreactivity in COVID-19.
Moody R; Wilson K; Flanagan KL; Jaworowski A; Plebanski M
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445670
[TBL] [Abstract][Full Text] [Related]
2. Untangling COVID-19 and autoimmunity: Identification of plausible targets suggests multi organ involvement.
Mohkhedkar M; Venigalla SSK; Janakiraman V
Mol Immunol; 2021 Sep; 137():105-113. PubMed ID: 34242919
[TBL] [Abstract][Full Text] [Related]
3. COVID-19 and autoimmune diseases.
Liu Y; Sawalha AH; Lu Q
Curr Opin Rheumatol; 2021 Mar; 33(2):155-162. PubMed ID: 33332890
[TBL] [Abstract][Full Text] [Related]
4. Enhanced Expression of Autoantigens During SARS-CoV-2 Viral Infection.
Saheb Sharif-Askari N; Saheb Sharif-Askari F; Ahmed SBM; Hannawi S; Hamoudi R; Hamid Q; Halwani R
Front Immunol; 2021; 12():686462. PubMed ID: 34276672
[TBL] [Abstract][Full Text] [Related]
5. Autoimmune complications of COVID-19.
Yazdanpanah N; Rezaei N
J Med Virol; 2022 Jan; 94(1):54-62. PubMed ID: 34427929
[TBL] [Abstract][Full Text] [Related]
6. Stress proteins, autoimmunity, and autoimmune disease.
Winfield JB; Jarjour WN
Curr Top Microbiol Immunol; 1991; 167():161-89. PubMed ID: 2055095
[TBL] [Abstract][Full Text] [Related]
7. False Positive Results in SARS-CoV-2 Serological Tests for Samples From Patients With Chronic Inflammatory Diseases.
Kharlamova N; Dunn N; Bedri SK; Jerling S; Almgren M; Faustini F; Gunnarsson I; Rönnelid J; Pullerits R; Gjertsson I; Lundberg K; Månberg A; Pin E; Nilsson P; Hober S; Fink K; Fogdell-Hahn A
Front Immunol; 2021; 12():666114. PubMed ID: 34012450
[TBL] [Abstract][Full Text] [Related]
8. Understanding immunopathological fallout of human coronavirus infections including COVID-19: Will they cross the path of rheumatologists?
Kabeerdoss J; Danda D
Int J Rheum Dis; 2020 Aug; 23(8):998-1008. PubMed ID: 32779341
[TBL] [Abstract][Full Text] [Related]
9. Selfie: Autoimmunity, boon or bane.
Ahsan H
J Immunoassay Immunochem; 2017; 38(3):235-246. PubMed ID: 28421864
[TBL] [Abstract][Full Text] [Related]
10. Emerging Roles of Coronavirus in Autoimmune Diseases.
Zhou SY; Zhang C; Shu WJ; Chong LY; He J; Xu Z; Pan HF
Arch Med Res; 2021 Oct; 52(7):665-672. PubMed ID: 33875273
[TBL] [Abstract][Full Text] [Related]
11. SARS-CoV-2 infection as a trigger of autoimmune response.
Sacchi MC; Tamiazzo S; Stobbione P; Agatea L; De Gaspari P; Stecca A; Lauritano EC; Roveta A; Tozzoli R; Guaschino R; Bonometti R
Clin Transl Sci; 2021 May; 14(3):898-907. PubMed ID: 33306235
[TBL] [Abstract][Full Text] [Related]
12. Molecular mimicry, hyperactive immune system, and SARS-COV-2 are three prerequisites of the autoimmune disease triangle following COVID-19 infection.
Vahabi M; Ghazanfari T; Sepehrnia S
Int Immunopharmacol; 2022 Nov; 112():109183. PubMed ID: 36182877
[TBL] [Abstract][Full Text] [Related]
13. SARS-CoV-2 triggering autoimmune diseases.
Mobasheri L; Nasirpour MH; Masoumi E; Azarnaminy AF; Jafari M; Esmaeili SA
Cytokine; 2022 Jun; 154():155873. PubMed ID: 35461172
[TBL] [Abstract][Full Text] [Related]
14. New Onset of Autoimmune Diseases Following COVID-19 Diagnosis.
Gracia-Ramos AE; Martin-Nares E; Hernández-Molina G
Cells; 2021 Dec; 10(12):. PubMed ID: 34944099
[TBL] [Abstract][Full Text] [Related]
15. Rheumatoid arthritis and systemic lupus erythematosus as immune complex diseases.
Weissmann G
Bull NYU Hosp Jt Dis; 2009; 67(3):251-3. PubMed ID: 19852746
[TBL] [Abstract][Full Text] [Related]
16. Neuronal BC RNA Transport Impairments Caused by Systemic Lupus Erythematosus Autoantibodies.
Muslimov IA; Iacoangeli A; Eom T; Ruiz A; Lee M; Stephenson S; Ginzler EM; Tiedge H
J Neurosci; 2019 Sep; 39(39):7759-7777. PubMed ID: 31405929
[TBL] [Abstract][Full Text] [Related]
17. Potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases.
Vojdani A; Kharrazian D
Clin Immunol; 2020 Aug; 217():108480. PubMed ID: 32461193
[No Abstract] [Full Text] [Related]
18. COVID-19 and SLE: Infection and autoimmunity at its best.
Mahroum N; Elsalti A; Ozkan MF; Shoenfeld Y
Lupus; 2023 Dec; 32(14):1591-1597. PubMed ID: 37927085
[TBL] [Abstract][Full Text] [Related]
19. The use of post-translationally modified peptides for detection of biomarkers of immune-mediated diseases.
Papini AM
J Pept Sci; 2009 Oct; 15(10):621-8. PubMed ID: 19714713
[TBL] [Abstract][Full Text] [Related]
20. Seronegative autoimmune diseases.
Alessandri C; Conti F; Conigliaro P; Mancini R; Massaro L; Valesini G
Ann N Y Acad Sci; 2009 Sep; 1173():52-9. PubMed ID: 19758132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
